Bridgepoint Group (LON:BPT - Get Free Report)'s stock had its "overweight" rating restated by equities researchers at JPMorgan Chase & Co. in a report released on Thursday, MarketBeat Ratings reports. They currently have a GBX 424 ($5.66) target price on the stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 23.42% from the company's current price.
Separately, Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a GBX 345 ($4.61) target price on shares of Bridgepoint Group in a research note on Monday, July 21st.
Check Out Our Latest Stock Analysis on Bridgepoint Group
Bridgepoint Group Price Performance
BPT opened at GBX 343.54 ($4.59) on Thursday. The company has a market capitalization of £2.84 billion, a price-to-earnings ratio of 62.41, a PEG ratio of 0.61 and a beta of 1.72. The company has a quick ratio of 3.60, a current ratio of 4.98 and a debt-to-equity ratio of 12.89. The firm has a 50-day moving average price of GBX 311.89 and a 200-day moving average price of GBX 315.47. Bridgepoint Group has a twelve month low of GBX 229.20 ($3.06) and a twelve month high of GBX 410 ($5.48).
Bridgepoint Group Company Profile
(
Get Free Report)
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bridgepoint Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bridgepoint Group wasn't on the list.
While Bridgepoint Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.